SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-014085
Filing Date
2024-02-12
Accepted
2024-02-12 20:12:04
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 6215
  Complete submission text file 0000950170-24-014085.txt   7608
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Robb Gary Charles (Reporting) CIK: 0001529655 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50679 | Film No.: 24622192